These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12608469)

  • 1. Increased farnesyltransferase activity in human colorectal cancer: relationship with clinicopathological features and K-ras mutation.
    Caruso MG; Notarnicola M; Bifulco M; Laezza C; Guerra V; Altomare DF; Memeo V; Lorusso D; Demma I; Di Leo A
    Scand J Gastroenterol; 2003 Jan; 38(1):80-5. PubMed ID: 12608469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the farnesyltransferase beta-subunit gene in human ovarian carcinoma: correlation to K-ras mutation.
    Tanimoto H; Mehta KD; Parmley TH; Shigemasa K; Parham GP; Clarke J; O'Brien TJ
    Gynecol Oncol; 1997 Aug; 66(2):308-12. PubMed ID: 9264581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K-ras and p53 mutations in DNA extracted from colonic epithelial cells exfoliated in faeces of patients with colorectal cancer.
    Notarnicola M; Cavallini A; Cardone R; Pezzolla F; Demma I; Di Leo A
    Dig Liver Dis; 2000 Mar; 32(2):131-6. PubMed ID: 10975788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype.
    Bazan V; Migliavacca M; Zanna I; Tubiolo C; Grassi N; Latteri MA; La Farina M; Albanese I; Dardanoni G; Salerno S; Tomasino RM; Labianca R; Gebbia N; Russo A
    Ann Oncol; 2002 Sep; 13(9):1438-46. PubMed ID: 12196370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular staging of colorectal cancer: K-ras mutation analysis of lymph nodes upstages Dukes B patients.
    Thebo JS; Senagore AJ; Reinhold DS; Stapleton SR
    Dis Colon Rectum; 2000 Feb; 43(2):155-9; discussion 159-62. PubMed ID: 10696887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical changes of mevalonate pathway in human colorectal cancer.
    Caruso MG; Notarnicola M
    Anticancer Res; 2005; 25(5):3393-7. PubMed ID: 16101154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K-ras and B-raf gene mutations are not associated with gastrin- and CCK2-receptor mRNA expression in human colorectal tumour tissues.
    Monstein HJ; Fransén K; Dimberg J; Söderkvist P
    Eur J Clin Invest; 2004 Feb; 34(2):100-6. PubMed ID: 14764072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of K-ras mutations throughout the natural history of human colorectal cancer.
    Losi L; Benhattar J; Costa J
    Eur J Cancer; 1992; 28A(6-7):1115-20. PubMed ID: 1627381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report.
    Sameer AS; Chowdhri NA; Abdullah S; Shah ZA; Siddiqi MA
    Indian J Cancer; 2009; 46(3):219-25. PubMed ID: 19574674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
    Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
    Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyamine biosynthesis in relation to K-ras and p-53 mutations in colorectal carcinoma.
    Linsalata M; Notarnicola M; Caruso MG; Di Leo A; Guerra V; Russo F
    Scand J Gastroenterol; 2004 May; 39(5):470-7. PubMed ID: 15180186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usefulness of K-RAS mutation detection in colorectal cancer and in surgical margins of the colon.
    Okulczyk B; Kovalchuk O; Piotrowski Z; Myśliwiec P; Chyczewski L
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():52-4. PubMed ID: 15638373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher farnesyl diphosphate synthase activity in human colorectal cancer inhibition of cellular apoptosis.
    Notarnicola M; Messa C; Cavallini A; Bifulco M; Tecce MF; Eletto D; Di Leo A; Montemurro S; Laezza C; Caruso MG
    Oncology; 2004; 67(5-6):351-8. PubMed ID: 15713990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
    Conzelmann M; Linnemann U; Berger MR
    Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frequency and clinicopathological associations of K-ras mutations in Venezuelan patients with colo-rectal cancer].
    Estrada P; Rojas-Atencio A; Zabala W; Borjas L; Soca L; Urdaneta K; Alvarez-Nava F; Cañizales J; Rojas J; Soto M
    Invest Clin; 2009 Mar; 50(1):55-63. PubMed ID: 19418727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study.
    Lüchtenborg M; Weijenberg MP; Wark PA; Saritas AM; Roemen GM; van Muijen GN; de Bruïne AP; van den Brandt PA; de Goeij AF
    BMC Cancer; 2005 Dec; 5():160. PubMed ID: 16356174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The balanced induction of K-ras codon 12 and 13 mutations in mucosa differs from their ratio in neoplastic tissues.
    Kraus MC; Seelig MH; Linnemann U; Berger MR
    Int J Oncol; 2006 Oct; 29(4):957-64. PubMed ID: 16964391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and clinicopathology associations of K-ras mutations in colorectal cancer in a northeast Mexican population.
    Martinez-Garza SG; Núñez-Salazar A; Calderon-Garcidueñas AL; Bosques-Padilla FJ; Niderhauser-García A; Barrera-Saldaña HA
    Dig Dis; 1999; 17(4):225-9. PubMed ID: 10754362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K-ras mutations in colorectal adenocarcinomas and neighbouring transitional mucosa.
    Zhang H; Nordenskjöld B; Dufmats M; Söderkvist P; Sun XF
    Eur J Cancer; 1998 Dec; 34(13):2053-7. PubMed ID: 10070310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of farnesyltransferase with A-176120, a novel and potent farnesyl pyrophosphate analogue.
    Tahir SK; Gu WZ; Zhang HC; Leal J; Lee JY; Kovar P; Saeed B; Cherian SP; Devine E; Cohen J; Warner R; Wang YC; Stout D; Arendsen DL; Rosenberg S; Ng SC
    Eur J Cancer; 2000 Jun; 36(9):1161-70. PubMed ID: 10854950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.